• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Global knockout of ROMK potassium channel worsens cardiac ischemia-reperfusion injury but cardiomyocyte-specific knockout does not: Implications for the identity of mitoKATP.全球敲除 ROMK 钾通道会加重心脏缺血再灌注损伤,但心肌细胞特异性敲除则不会:对 mitoKATP 身份的影响。
J Mol Cell Cardiol. 2020 Feb;139:176-189. doi: 10.1016/j.yjmcc.2020.01.010. Epub 2020 Jan 29.
2
Pharmacologic ROMK Inhibition Protects Against Myocardial Ischemia Reperfusion Injury.药理学抑制ROMK可预防心肌缺血再灌注损伤。
Int J Mol Sci. 2025 Apr 17;26(8):3795. doi: 10.3390/ijms26083795.
3
Role of mitochondrial permeability transition pore and mitochondrial ATP-sensitive potassium channels in the protective effects of ischemic preconditioning in isolated hearts from fed and fasted rats.线粒体通透性转换孔和线粒体ATP敏感性钾通道在喂食和禁食大鼠离体心脏缺血预处理保护作用中的作用
J Physiol Biochem. 2014 Sep;70(3):791-800. doi: 10.1007/s13105-014-0347-y. Epub 2014 Jul 19.
4
Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?抑制线粒体通透性转换孔开放:心肌预处理的新范例?
Cardiovasc Res. 2002 Aug 15;55(3):534-43. doi: 10.1016/s0008-6363(02)00455-8.
5
Calcium-activated potassium channel triggers cardioprotection of ischemic preconditioning.钙激活钾通道触发缺血预处理的心脏保护作用。
J Pharmacol Exp Ther. 2005 Feb;312(2):644-50. doi: 10.1124/jpet.104.074476. Epub 2004 Sep 2.
6
Mitochondrial ROMK channel is a molecular component of mitoK(ATP).线粒体 ROMK 通道是 mitoK(ATP)的分子组成部分。
Circ Res. 2012 Aug 3;111(4):446-54. doi: 10.1161/CIRCRESAHA.112.266445. Epub 2012 Jul 17.
7
Pre-treatment of a single high-dose of atorvastatin provided cardioprotection in different ischaemia/reperfusion models via activating mitochondrial KATP channel.单次大剂量阿托伐他汀预处理通过激活线粒体ATP敏感性钾通道在不同的缺血/再灌注模型中提供心脏保护作用。
Eur J Pharmacol. 2015 Mar 15;751:89-98. doi: 10.1016/j.ejphar.2015.01.036. Epub 2015 Jan 30.
8
A glibenclamide analog lacking the cyclohexylurea portion fails to block ischemic preconditioning-induced mitochondrial and cardiac protection against ischemia/reperfusion injury.一种缺乏环己基脲部分的格列本脲类似物无法阻断缺血预处理诱导的线粒体和心脏对缺血/再灌注损伤的保护作用。
Arch Biochem Biophys. 2025 Jul;769:110418. doi: 10.1016/j.abb.2025.110418. Epub 2025 Apr 8.
9
Single-Channel Properties of the ROMK-Pore-Forming Subunit of the Mitochondrial ATP-Sensitive Potassium Channel.线粒体 ATP 敏感性钾通道 ROMK 孔形成亚单位的单通道特性。
Int J Mol Sci. 2019 Oct 25;20(21):5323. doi: 10.3390/ijms20215323.
10
Oxytocin protects cardiomyocytes from apoptosis induced by ischemia-reperfusion in rat heart: role of mitochondrial ATP-dependent potassium channel and permeability transition pore.催产素通过线粒体 ATP 依赖性钾通道和通透性转换孔保护大鼠心肌细胞免受缺血再灌注诱导的细胞凋亡:作用机制。
Peptides. 2012 Jul;36(1):71-7. doi: 10.1016/j.peptides.2012.03.023. Epub 2012 Apr 5.

引用本文的文献

1
Pharmacologic ROMK Inhibition Protects Against Myocardial Ischemia Reperfusion Injury.药理学抑制ROMK可预防心肌缺血再灌注损伤。
Int J Mol Sci. 2025 Apr 17;26(8):3795. doi: 10.3390/ijms26083795.
2
Association of TyG index and central obesity with hypertension in middle-aged and elderly Chinese adults: a prospective cohort study.中国中老年成年人中TyG指数及中心性肥胖与高血压的关联:一项前瞻性队列研究
Sci Rep. 2024 Jan 26;14(1):2235. doi: 10.1038/s41598-024-52342-7.
3
Kir1.1 and SUR1 are not implicated as subunits of an adenosine triphosphate-sensitive potassium channel involved in diazoxide cardioprotection.Kir1.1和SUR1并不作为参与二氮嗪心脏保护作用的三磷酸腺苷敏感性钾通道的亚基。
JTCVS Open. 2023 Jun 16;15:231-241. doi: 10.1016/j.xjon.2023.06.004. eCollection 2023 Sep.
4
Overexpression of a Short Sulfonylurea Splice Variant Increases Cardiac Glucose Uptake and Uncouples Mitochondria by Regulating ROMK Activity.一种短链磺脲类剪接变体的过表达通过调节ROMK活性增加心脏葡萄糖摄取并使线粒体解偶联。
Life (Basel). 2023 Apr 14;13(4):1015. doi: 10.3390/life13041015.
5
Functional Regulation of K Channels and Mutant Insight Into Clinical Therapeutic Strategies in Cardiovascular Diseases.钾通道的功能调节及心血管疾病临床治疗策略的突变体见解
Front Pharmacol. 2022 Jun 28;13:868401. doi: 10.3389/fphar.2022.868401. eCollection 2022.
6
The Mitochondrial Routing of the Kv1.3 Channel.Kv1.3通道的线粒体定位
Front Oncol. 2022 Mar 24;12:865686. doi: 10.3389/fonc.2022.865686. eCollection 2022.
7
Rethinking Mitchell's Chemiosmotic Theory: Potassium Dominates Over Proton Flux to Drive Mitochondrial FF-ATP Synthase.重新审视米切尔的化学渗透理论:钾离子在驱动线粒体F₁F₀-ATP合酶方面比质子通量起主导作用。
Function (Oxf). 2022 Mar 9;3(2):zqac012. doi: 10.1093/function/zqac012. eCollection 2022.
8
Chemotherapy Resistance: Role of Mitochondrial and Autophagic Components.化疗耐药性:线粒体和自噬成分的作用
Cancers (Basel). 2022 Mar 12;14(6):1462. doi: 10.3390/cancers14061462.
9
ATP Synthase K- and H-fluxes Drive ATP Synthesis and Enable Mitochondrial K-"Uniporter" Function: II. Ion and ATP Synthase Flux Regulation.ATP 合酶 K- 和 H- 流驱动 ATP 合成并使线粒体 K-"单向转运体"功能成为可能:二、离子和 ATP 合酶流的调节。
Function (Oxf). 2022 Jan 27;3(2):zqac001. doi: 10.1093/function/zqac001. eCollection 2022.
10
Alternative Targets for Modulators of Mitochondrial Potassium Channels.线粒体钾通道调节剂的替代靶标。
Molecules. 2022 Jan 4;27(1):299. doi: 10.3390/molecules27010299.

本文引用的文献

1
Single-Channel Properties of the ROMK-Pore-Forming Subunit of the Mitochondrial ATP-Sensitive Potassium Channel.线粒体 ATP 敏感性钾通道 ROMK 孔形成亚单位的单通道特性。
Int J Mol Sci. 2019 Oct 25;20(21):5323. doi: 10.3390/ijms20215323.
2
Identification of an ATP-sensitive potassium channel in mitochondria.鉴定线粒体中的 ATP 敏感性钾通道。
Nature. 2019 Aug;572(7771):609-613. doi: 10.1038/s41586-019-1498-3. Epub 2019 Aug 21.
3
Optimized Treatment of ST-Elevation Myocardial Infarction.优化 ST 段抬高型心肌梗死的治疗。
Circ Res. 2019 Jul 5;125(2):245-258. doi: 10.1161/CIRCRESAHA.119.315344. Epub 2019 Jul 3.
4
Evidence for a mitochondrial ATP-regulated potassium channel in human dermal fibroblasts.人皮肤成纤维细胞中线粒体 ATP 调节钾通道的证据。
Biochim Biophys Acta Bioenerg. 2018 May;1859(5):309-318. doi: 10.1016/j.bbabio.2018.02.005. Epub 2018 Feb 16.
5
Urinary bladder hypertrophy characteristic of male ROMK Bartter's mice does not occur in female mice.雄性ROMK巴特综合征小鼠所特有的膀胱肥大现象在雌性小鼠中不会出现。
Am J Physiol Regul Integr Comp Physiol. 2018 Mar 1;314(3):R334-R341. doi: 10.1152/ajpregu.00315.2017. Epub 2017 Nov 1.
6
The Slo(w) path to identifying the mitochondrial channels responsible for ischemic protection.识别负责缺血保护的线粒体通道的缓慢之路。
Biochem J. 2017 Jun 9;474(12):2067-2094. doi: 10.1042/BCJ20160623.
7
Survival and growth of C57BL/6J mice lacking the BK channel, : lower adult body weight occurs together with higher body fat.缺乏BK通道的C57BL/6J小鼠的存活与生长:成年体重较低与体脂较高同时出现。
Physiol Rep. 2017 Feb;5(4). doi: 10.14814/phy2.13137. Epub 2017 Feb 27.
8
Non-cell autonomous cues for enhanced functionality of human embryonic stem cell-derived cardiomyocytes via maturation of sarcolemmal and mitochondrial K channels.通过肌膜和线粒体钾通道成熟增强人胚胎干细胞衍生心肌细胞功能的非细胞自主信号
Sci Rep. 2016 Sep 28;6:34154. doi: 10.1038/srep34154.
9
Discovery of MK-7145, an Oral Small Molecule ROMK Inhibitor for the Treatment of Hypertension and Heart Failure.用于治疗高血压和心力衰竭的口服小分子ROMK抑制剂MK-7145的发现。
ACS Med Chem Lett. 2016 May 12;7(7):697-701. doi: 10.1021/acsmedchemlett.6b00122. eCollection 2016 Jul 14.
10
The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter's Syndrome Type II Phenotype.肾外髓质钾通道抑制剂MK-7145可降低血压,并表现出II型巴特综合征的特征。
J Pharmacol Exp Ther. 2016 Oct;359(1):194-206. doi: 10.1124/jpet.116.235150. Epub 2016 Jul 18.

全球敲除 ROMK 钾通道会加重心脏缺血再灌注损伤,但心肌细胞特异性敲除则不会:对 mitoKATP 身份的影响。

Global knockout of ROMK potassium channel worsens cardiac ischemia-reperfusion injury but cardiomyocyte-specific knockout does not: Implications for the identity of mitoKATP.

机构信息

Division of Cardiology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Cardiovascular Branch, NHLBI, NIH, 10 Center Drive, Bethesda, MD, USA.

出版信息

J Mol Cell Cardiol. 2020 Feb;139:176-189. doi: 10.1016/j.yjmcc.2020.01.010. Epub 2020 Jan 29.

DOI:10.1016/j.yjmcc.2020.01.010
PMID:32004507
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7849919/
Abstract

The renal-outer-medullary‑potassium (ROMK) channel, mutated in Bartter's syndrome, regulates ion exchange in kidney, but its extra-renal functions remain unknown. Additionally, ROMK was postulated to be the pore-forming subunit of the mitochondrial ATP-sensitive K channel (mitoK), a mediator of cardioprotection. Using global and cardiomyocyte-specific knockout mice (ROMK-GKO and ROMK-CKO respectively), we characterize the effects of ROMK knockout on mitochondrial ion handling, the response to pharmacological K channel modulators, and ischemia/reperfusion (I/R) injury. Mitochondria from ROMK-GKO hearts exhibited a lower threshold for Ca-triggered permeability transition pore (mPTP) opening but normal matrix volume changes during oxidative phosphorylation. Isolated perfused ROMK-GKO hearts exhibited impaired functional recovery and increased infarct size when I/R was preceded by an ischemic preconditioning (IPC) protocol. Because ROMK-GKO mice exhibited severe renal defects and cardiac remodeling, we further characterized ROMK-CKO hearts to avoid confounding systemic effects. Mitochondria from ROMK-CKO hearts had unchanged matrix volume responses during oxidative phosphorylation and still swelled upon addition of a mitoK opener, but exhibited a lower threshold for mPTP opening, similar to GKO mitochondria. Nevertheless, I/R induced damage was not exacerbated in ROMK-CKO hearts, either ex vivo or in vivo. Lastly, we examined the response of ROMK-CKO hearts to ex vivo I/R injury with or without IPC and found that IPC still protected these hearts, suggesting that cardiomyocyte ROMK does not participate significantly in the cardioprotective pathway elicited by IPC. Collectively, our findings from these novel strains of mice suggest that cardiomyocyte ROMK is not a central mediator of mitoK function, although it can affect mPTP activation threshold.

摘要

肾外髓质钾 (ROMK) 通道在 Bartter 综合征中发生突变,调节肾脏中的离子交换,但它的肾脏外功能仍不清楚。此外,ROMK 被假定为线粒体 ATP 敏感性钾通道 (mitoK) 的孔形成亚基,mitoK 是心脏保护的介质。使用全局和心肌细胞特异性敲除小鼠(ROMK-GKO 和 ROMK-CKO),我们分别描述了 ROMK 敲除对线粒体离子处理、对药理学 K 通道调节剂的反应以及缺血/再灌注 (I/R) 损伤的影响。ROMK-GKO 心脏的线粒体表现出较低的 Ca 触发通透性转换孔 (mPTP) 开放的阈值,但在氧化磷酸化过程中基质体积变化正常。当 I/R 之前进行缺血预处理 (IPC) 方案时,分离的灌注 ROMK-GKO 心脏表现出功能恢复受损和梗死面积增加。由于 ROMK-GKO 小鼠表现出严重的肾脏缺陷和心脏重构,我们进一步对 ROMK-CKO 心脏进行了特征描述,以避免混淆全身效应。ROMK-CKO 心脏的线粒体在氧化磷酸化过程中基质体积反应不变,并且在加入 mitoK 开放剂时仍然肿胀,但 mPTP 开放的阈值较低,类似于 GKO 线粒体。然而,在 ROMK-CKO 心脏中,I/R 诱导的损伤在体内或体外均未加重。最后,我们检查了 ROMK-CKO 心脏对离体 I/R 损伤的反应,有无 IPC,并发现 IPC 仍然保护这些心脏,表明心肌细胞 ROMK 并没有显著参与 IPC 引起的心脏保护途径。总之,从这些新型小鼠品系中获得的研究结果表明,心肌细胞 ROMK 不是 mitoK 功能的中心介质,尽管它可以影响 mPTP 激活阈值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e326/7849919/993aafdb89c9/nihms-1558026-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e326/7849919/fa4033abead4/nihms-1558026-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e326/7849919/624d43207e49/nihms-1558026-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e326/7849919/e8ee890aeeb9/nihms-1558026-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e326/7849919/3cfa6fd6323e/nihms-1558026-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e326/7849919/619e99cb6e99/nihms-1558026-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e326/7849919/d2a6e7cd9a1d/nihms-1558026-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e326/7849919/e6137455c48a/nihms-1558026-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e326/7849919/993aafdb89c9/nihms-1558026-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e326/7849919/fa4033abead4/nihms-1558026-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e326/7849919/624d43207e49/nihms-1558026-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e326/7849919/e8ee890aeeb9/nihms-1558026-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e326/7849919/3cfa6fd6323e/nihms-1558026-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e326/7849919/619e99cb6e99/nihms-1558026-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e326/7849919/d2a6e7cd9a1d/nihms-1558026-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e326/7849919/e6137455c48a/nihms-1558026-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e326/7849919/993aafdb89c9/nihms-1558026-f0008.jpg